Title Flori Pharma : maintaining ethics in an unethical sales environment / by Muhammad Muzamil Sattar (Department of Marketing and Business Administration, the Sukkur Institute of Business Administration, Sukkur, Pakistan), Asad Ali Qazi (Department of Human Resource Management and Business Administration, the Sukkur Institute of Business Administration, Sukkur, Pakistan), Farhan Shahzad (Department of Supply Chain Management and Business Administration, the Sukkur Institute of Business Administration, Sukkur, Pakistan) and Abdul Rehman Shaikh (Directorate of IBA CC & S, Sukkur Institute of Business Administration, Sukkur, Pakistan)

Published Bingley, U.K. : Emerald Publishing Limited, 2020 ©2020

Online access available from: Emerald Emerging Markets    View Resource Record

Copies

Description 1 online resource (6 pages) : 21 illustrations Series Emerald emerging markets case studies, 2045-0621 ; volume 10, issue 1 Notes The learning outcomes are as follows: what tasks are to be done by medical representatives in pharmaceutical industry? This study also highlights various competencies required to do effective selling in this industry; analyzes and discusses different unethical practices going on in the market; explains why ethical norms are necessary in sales context when sales targets are already achievable with unethical means; and develops and comments on strategies Flori Pharmaceutical can make to overcome on these unethical issues. What should be the response of Dahar to the email of Naveed khan? What course of action should be taken by Dahar in the deceitful reporting case of Mohsin Ali? Flori is considered a leading and growing multinational organization in the highly competitive environment of Pakistan pharmaceutical industry with over 40years of experience. The company aims to command a leading position in developing new health-care products as it offers a wide range of diabetic, cardiovascular, respiratory and vitamin products based on quality as a result of high research and examination. Recently, an email to Bilal Dahar on March 2017 from Flori's star sales person Naveed Khan has forced management to take some strong decisions regarding ethical norms and values to be adopted by medical representatives of Flori pharmaceuticals. The email highlighted the issues related to sales pressure which are leading toward unethical sales practices. Dahar just not have to maintain Flori's ethical code of conduct but he and his team also has to work hard to achieve more than 26% growth rate in sales revenue as compared to last year. Dahar knew that the highly competitive environment of pharmaceutical industry has led most of the stake holders to indulge in unethical behavior to achieve their individual targets. He knew that this is dangerous in long term for the multinational organizations such as Flori pharmaceuticals as if the similar behavior continues, the sales culture and values of the organization would be on stake. He also has to decide what decision to be taken against deceitful reporting issue of one of the top-performer territory managers, who was key person in helping Flori to close the sales year 2016 with the revenue of Rs. 6.4bn, a 26% growth over the last year. The case is rich enough to provide a platform regarding management of several ethical challenges in pharmaceutical selling and developing strategies based on them BBA, MBA final year Teaching Notes are available for educators only Includes index Bibliography Includes bibliographical references Notes Print version record Subject Business ethics -- Case studies. Pharmaceutical industry -- Pakistan -- Case studies Business & Economics -- Business Ethics. Business ethics & social responsibility. Form Electronic book Author Qazi, Asad Ali, author Shahzad, Farhan, author Shaikh, Abdul Rehman, author

  Permalink